180 related articles for article (PubMed ID: 15814919)
1. Measurement of tumor "size" in recurrent malignant glioma: 1D, 2D, or 3D?
Dempsey MF; Condon BR; Hadley DM
AJNR Am J Neuroradiol; 2005 Apr; 26(4):770-6. PubMed ID: 15814919
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of magnetic resonance imaging-guided stereotactic biopsy in the evaluation of recurrent malignant astrocytoma compared with a lesion due to radiation effect.
McGirt MJ; Bulsara KR; Cummings TJ; New KC; Little KM; Friedman HS; Friedman AH
J Neurosurg; 2003 Jan; 98(1):14-20. PubMed ID: 12546347
[TBL] [Abstract][Full Text] [Related]
3. Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma.
Ellingson BM; Aftab DT; Schwab GM; Hessel C; Harris RJ; Woodworth DC; Leu K; Chakhoyan A; Raymond C; Drappatz J; de Groot J; Prados MD; Reardon DA; Schiff D; Chamberlain M; Mikkelsen T; Desjardins A; Holland J; Ping J; Weitzman R; Wen PY; Cloughesy TF
Neuro Oncol; 2018 Sep; 20(10):1411-1418. PubMed ID: 29660005
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide in the treatment of recurrent malignant glioma.
Chang SM; Theodosopoulos P; Lamborn K; Malec M; Rabbitt J; Page M; Prados MD
Cancer; 2004 Feb; 100(3):605-11. PubMed ID: 14745879
[TBL] [Abstract][Full Text] [Related]
5. Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression.
Huang RY; Unadkat P; Bi WL; George E; Preusser M; McCracken JD; Keen JR; Read WL; Olson JJ; Seystahl K; Le Rhun E; Roelcke U; Koeppen S; Furtner J; Weller M; Raizer JJ; Schiff D; Wen PY
Neuro Oncol; 2019 Feb; 21(2):234-241. PubMed ID: 30085283
[TBL] [Abstract][Full Text] [Related]
6. Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods.
Galanis E; Buckner JC; Maurer MJ; Sykora R; Castillo R; Ballman KV; Erickson BJ
Neuro Oncol; 2006 Apr; 8(2):156-65. PubMed ID: 16533757
[TBL] [Abstract][Full Text] [Related]
7. Comparison of one-, two-, and three-dimensional measurements of childhood brain tumors.
Warren KE; Patronas N; Aikin AA; Albert PS; Balis FM
J Natl Cancer Inst; 2001 Sep; 93(18):1401-5. PubMed ID: 11562391
[TBL] [Abstract][Full Text] [Related]
8. Semiautomated volumetric measurement on postcontrast MR imaging for analysis of recurrent and residual disease in glioblastoma multiforme.
Chow DS; Qi J; Guo X; Miloushev VZ; Iwamoto FM; Bruce JN; Lassman AB; Schwartz LH; Lignelli A; Zhao B; Filippi CG
AJNR Am J Neuroradiol; 2014 Mar; 35(3):498-503. PubMed ID: 23988756
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
10. Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas.
Shah GD; Kesari S; Xu R; Batchelor TT; O'Neill AM; Hochberg FH; Levy B; Bradshaw J; Wen PY
Neuro Oncol; 2006 Jan; 8(1):38-46. PubMed ID: 16443946
[TBL] [Abstract][Full Text] [Related]
11. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
[TBL] [Abstract][Full Text] [Related]
12. Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma.
Vos MJ; Hoekstra OS; Barkhof F; Berkhof J; Heimans JJ; van Groeningen CJ; Vandertop WP; Slotman BJ; Postma TJ
J Clin Oncol; 2003 Oct; 21(19):3559-65. PubMed ID: 12913097
[TBL] [Abstract][Full Text] [Related]
13. Advantages of high b-value diffusion-weighted imaging to diagnose pseudo-responses in patients with recurrent glioma after bevacizumab treatment.
Yamasaki F; Kurisu K; Aoki T; Yamanaka M; Kajiwara Y; Watanabe Y; Takayasu T; Akiyama Y; Sugiyama K
Eur J Radiol; 2012 Oct; 81(10):2805-10. PubMed ID: 22100373
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Two-Dimensional Size of Glioblastoma is Associated with Patient Survival.
Leu S; Boulay JL; Thommen S; Bucher HC; Stippich C; Mariani L; Bink A
World Neurosurg; 2018 Jul; 115():e448-e463. PubMed ID: 29678715
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.
Reardon DA; Quinn JA; Rich JN; Desjardins A; Vredenburgh J; Gururangan S; Sathornsumetee S; Badruddoja M; McLendon R; Provenzale J; Herndon JE; Dowell JM; Burkart JL; Newton HB; Friedman AH; Friedman HS
Cancer; 2005 Oct; 104(7):1478-86. PubMed ID: 16088964
[TBL] [Abstract][Full Text] [Related]
16. Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study.
Karunanithi S; Sharma P; Kumar A; Gupta DK; Khangembam BC; Ballal S; Kumar R; Kumar R; Bal C
Eur J Radiol; 2014 Jan; 83(1):219-25. PubMed ID: 24191944
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature.
Chaichana KL; McGirt MJ; Niranjan A; Olivi A; Burger PC; Quinones-Hinojosa A
Neurol Res; 2009 Nov; 31(9):931-9. PubMed ID: 19215664
[TBL] [Abstract][Full Text] [Related]
18. Impact of
Debus C; Waltenberger M; Floca R; Afshar-Oromieh A; Bougatf N; Adeberg S; Heiland S; Bendszus M; Wick W; Rieken S; Haberkorn U; Debus J; Knoll M; Abdollahi A
Sci Rep; 2018 May; 8(1):7201. PubMed ID: 29740097
[TBL] [Abstract][Full Text] [Related]
19. Use of (11)C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma.
Chiba Y; Kinoshita M; Okita Y; Tsuboi A; Isohashi K; Kagawa N; Fujimoto Y; Oji Y; Oka Y; Shimosegawa E; Morita S; Hatazawa J; Sugiyama H; Hashimoto N; Yoshimine T
J Neurosurg; 2012 Apr; 116(4):835-42. PubMed ID: 22242671
[TBL] [Abstract][Full Text] [Related]
20. Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article.
Ius T; Isola M; Budai R; Pauletto G; Tomasino B; Fadiga L; Skrap M
J Neurosurg; 2012 Dec; 117(6):1039-52. PubMed ID: 23039150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
